3 recruiting. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Recruiting 3 |
| Phase 1 | 2 | Recruiting 2 |
Follow T Cell Lymphoma: new trials by email Literature Review of T Cell Lymphoma trials Research Report on T Cell Lymphoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Mogamulizumab With DA-EPOCH or CHOEP in Patients With Aggressive T-cell Lymphoma Mogamulizumab, DA-EPOCH Protocol, CHOEP protocol - T Cell Lymphoma, T-cell Lymphoma | Phase 2 | Recruiting | Yale University | 22 | 2024-10-09 | 2026-04-14 |
| Sequential CAR-T Cells Therapy for CD5/CD7 Positive T-cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma Using CD5/CD7-Specific CAR-T Cells CD5/CD7 CAR-T - T Cell Lymphoma, T Cell Leukemia | Phase 1 / Phase 2 | Recruiting | Essen Biotech | 60 | 2024-07-10 | 2024-11-12 |
| Azacitidine-CHOP for Patients With Nodal T-cell Lymphoma With T-follicular Helper Phenotype (ACANTUS) ACHOP - T Cell Lymphoma | Phase 1 / Phase 2 | Recruiting | Won Seog Kim | 41 | 2022-07-01 | 2023-10-23 |
Lymphoma, T-Cell (3) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (2) · Leukemia, Prolymphocytic, T-Cell (1) · Leukemia, T-Cell (1) · Lymphoma, T-Cell, Cutaneous (1) · Recurrence (1)
Hemic and Lymphatic Diseases (3) · Immune System Diseases (3) · Immunoproliferative Disorders (3) · Lymphatic Diseases (3) · Lymphoma (3) · Lymphoma, Non-Hodgkin (3) · Lymphoproliferative Disorders (3) · Neoplasms (3) · Neoplasms by Histologic Type (3) · Hematologic Diseases (2) · Leukemia (2) · Leukemia, Lymphoid (2) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (2) · Disease Attributes (1) · Leukemia, Prolymphocytic (1)
CHOEP protocol (1) · Cyclophosphamide (1) · Doxorubicin (1) · EPOCH protocol (1) · Etoposide (1) · Prednisone (1) · Vincristine (1) · mogamulizumab (1)
Essen Biotech (1) · Won Seog Kim (1) · Yale University (1)
China (1) · South Korea (1) · United States (1)